AARD News

Levi & Korsinsky Urges Aardvark Therapeutics, Inc. (AARD) Shareholders to Act Before Lead Plaintiff Deadline October 13, 2026

Class Action Lawsuit Alert: Levi & Korsinsky Reminds Aardvark Therapeutics, Inc. (AARD) Investors of October 13, 2026 Deadline

Class Action Litigation Filed by Pomerantz LLP Against Aardvark Therapeutics, Inc. – AARD

AARDVARK THERAPEUTICS (NASDAQ: AARD) SECURITIES CLASS ACTION: ROSEN, A TOP RANKED LAW FIRM, Encourages Investors with Losses in Excess of $100K to Secure Counsel Before Important October 13 Deadline

AARD SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aardvark Therapeutics, Inc. Investors Have Opportunity to Lead Class Action Lawsuit!

AARD Deadline: Rosen Law Firm Urges Aardvark Therapeutics, Inc. (NASDAQ: AARD) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights

AARD Shareholder Alert: October 13, 2026 Lead Plaintiff Deadline in Aardvark Therapeutics, Inc. Securities Class Action - Contact Levi & Korsinsky

Class Action Filed by Pomerantz LLP Against Aardvark Therapeutics, Inc. – AARD

AARD ALERT: Securities Fraud Class Action Launched Against Aardvark Therapeutics, Inc. - October 13, 2026 Deadline

Investor Alert: Deadline Approaching to Join Aardvark Therapeutics, Inc. (AARD) Class Action - Contact Levi & Korsinsky